Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Co-delivery of camptothecin and MiR-145 by lipid nanoparticles for MRI-visible targeted therapy of hepatocellular carcinoma
Rong Jing, Tongtong Liu, Xiujuan Yin, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Biomolecule-based engineered nanoparticles for Cancer Theranostics
Narayanan Parthasarathy, Ramar Thangam, Babu Rithisa, et al.
Coordination Chemistry Reviews (2025) Vol. 530, pp. 216489-216489
Closed Access | Times Cited: 1
RNA nanotherapeutics for hepatocellular carcinoma treatment
Yihang Yuan, Weijie Sun, Jiaqi Xie, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 965-992
Closed Access | Times Cited: 5
PAMAM/miR-144 Nanocarrier System Inhibits the Migration of Gastric Cancer by Targeting mTOR Signal Transduction Pathway
Yuanyuan Qian, Dongxu Zhu, XU Qiong, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114492-114492
Closed Access
Circular RNAs modulate cancer drug resistance: advances and challenges
Jinghan Hua, Zhe Wang, Xiangfei Cheng, et al.
Cancer Drug Resistance (2025)
Open Access
Design and Synthesis of Isatin Derivative Payloaded Peptide-Drug Conjugate as Tubulin Inhibitor against Colorectal Cancer
Guoyang Sun, Zhao‐Yang Wang, Yanping Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117276-117276
Closed Access
Comprehensive insights of etiological drivers of hepatocellular carcinoma: Fostering targeted nano delivery to anti-cancer regimes
Dipanjan Ghosh, Aharna Guin, Ashok Kumar, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189318-189318
Closed Access
MicroRNA-targeted nanoparticle delivery systems for cancer therapy: current status and future prospects
Yang Lou, Yutian Wang, Juan Lu, et al.
Nanomedicine (2025), pp. 1-14
Closed Access
Bovine serum albumin-Camptothecin nanoparticles for RNAs packaging to improve the prognosis of Cancer
Yun Tao Song, Hui Liu, Nannan Zhao, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136997-136997
Closed Access | Times Cited: 1
Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC)
Mingxuan Zhang, Ruiping Guo, Zhuhui Yuan, et al.
Global Challenges (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Mitochondrial HKDC1 suppresses oxidative stress and apoptosis by regulating mitochondrial function in goose fatty liver
Ya Xing, Jing Ge, Yuqing Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137222-137222
Closed Access
Unveiling the challenges of short non-coding RNAs and their prospects in cancer therapy
Loganathan Chandramani Priya Dharshini, Abul Kalam Azad Mandal
Journal of Drug Delivery Science and Technology (2024), pp. 106411-106411
Closed Access
Drug combinations of camptothecin derivatives promote the antitumor properties
Zhen Liu, Yajie Yuan, Ning Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116872-116872
Closed Access
Page 1

Scroll to top